| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/12/2007 | WO2007040436A1 Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040435A1 Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| 04/12/2007 | WO2007040426A1 Antiviral agent |
| 04/12/2007 | WO2007040345A1 Composition comprising tanshinone compounds isolated from the extract of salviae miltiorrhizae radix for treating or preventing cognitive dysfunction and the use thereof |
| 04/12/2007 | WO2007040326A1 A novel oxazolidinone formamide derivative and preparation method therof |
| 04/12/2007 | WO2007040306A1 A solid dispersion comprising sibutramine and surfactants, and a preparation method thereof |
| 04/12/2007 | WO2007040289A1 Deformylase inhibitor, process for the preparation thereof, and composition comprising the same |
| 04/12/2007 | WO2007040244A1 Composition for relieving subjective symptoms of fatigue |
| 04/12/2007 | WO2007040240A1 Optically active cyclic alcohol compound and method for producing same |
| 04/12/2007 | WO2007040238A1 Process for production of optically active 4-hydroxy-1,2,3,4 -tetrahydroquinolines |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007040188A1 Medicinal composition for inhibiting the excessive formation of goblet cells |
| 04/12/2007 | WO2007040166A1 Novel fused pyrrole derivative |
| 04/12/2007 | WO2007040128A1 Therapeutic agent for heart failure |
| 04/12/2007 | WO2007040082A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 04/12/2007 | WO2007040006A1 Activator for peroxisome proliferator-activated receptor (pparϝ) and composition containing the activator for preventing or ameliorating specific symptom |
| 04/12/2007 | WO2007040005A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPARα) AND COMPOSITION CONTAINING THE ACTIVATOR FOR PREVENTING OR AMELIORATING SPECIFIC SYMPTOM |
| 04/12/2007 | WO2007039976A1 Abnormal protein removing composition |
| 04/12/2007 | WO2007039945A1 Lipid metabolism improving composition |
| 04/12/2007 | WO2007039919A1 Crystalline forms of anastrozole |
| 04/12/2007 | WO2007039909A2 Compositions and methods for treatment of renal failure |
| 04/12/2007 | WO2007039904A2 Method and system for securing input from an external device to a host |
| 04/12/2007 | WO2007039902A2 Vessel treatment devices |
| 04/12/2007 | WO2007039884A1 3 -azabicyclooctane derivatives as muscarinic receptor antagonists |
| 04/12/2007 | WO2007039883A2 Process for preparation of aprepitant |
| 04/12/2007 | WO2007039869A2 Use of neboglamine in the treatment of toxicodependency |
| 04/12/2007 | WO2007039821A2 Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics |
| 04/12/2007 | WO2007039809A1 Metabolites of 2- {3-[4-(5-fluoro-2-isopropoxy-phenyl)-piperazin-1-yl]-propyl} -5,6-dihydroxy-hexahydro-isoindole-1,3-dione |
| 04/12/2007 | WO2007039802A1 Inhibitors of the hiv integrase enzyme |
| 04/12/2007 | WO2007039797A1 Use of cannabinoid receptor-1 antagonist for treating inflammation and arthritis |
| 04/12/2007 | WO2007039784A2 A novel crystalline polymorph of fluvastatin sodium and process for preparing it |
| 04/12/2007 | WO2007039782A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors |
| 04/12/2007 | WO2007039781A2 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors |
| 04/12/2007 | WO2007039773A1 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors |
| 04/12/2007 | WO2007039760A2 Use of oligouronates for treating mucus hyperviscosity |
| 04/12/2007 | WO2007039754A1 Use of oligouronates for treating mucus hyperviscosity |
| 04/12/2007 | WO2007039752A1 Alkyl 4- [4- (5-oxo-2, 3, 5, 11a-tetrahyd0-5h-pyrr0l0 [2, 1-c] [1, 4] benzodiazepine-8-yloxy) -butyrylamino]-1h-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease |
| 04/12/2007 | WO2007039749A2 Antibacterial pyrrols |
| 04/12/2007 | WO2007039741A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 04/12/2007 | WO2007039740A2 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders |
| 04/12/2007 | WO2007039635A2 Phosphoantigen salts of organic bases and methods for their crystallization |
| 04/12/2007 | WO2007039616A1 Pharmaceutically active tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides |
| 04/12/2007 | WO2007039609A1 Pyranodibenzofuran derivatives with antifungal and antibacterial activity |
| 04/12/2007 | WO2007039592A1 Polyunsaturated fatty acids as bace inhibitors |
| 04/12/2007 | WO2007039581A1 Imidazolyl-substituted diazabenzophenone compounds |
| 04/12/2007 | WO2007039580A1 Imidazolyl-substituted benzophenone compounds |
| 04/12/2007 | WO2007039578A1 Imidazolyl-substituted azabenzophenone compounds |
| 04/12/2007 | WO2007039572A1 Improved anti-fungal composition |
| 04/12/2007 | WO2007039563A1 9-azabicyclo [3 . 3 . 1] nonane derivatives as monoamine reuptake inhibitors |
| 04/12/2007 | WO2007039544A1 Novel c18 modified retrosteroids as progesterone receptor modulator compounds |
| 04/12/2007 | WO2007039526A1 Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof |
| 04/12/2007 | WO2007039512A1 Naphthyridin derivatives |
| 04/12/2007 | WO2007039482A1 Thiophene derivatives for the treatment of diabetes |
| 04/12/2007 | WO2007039470A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/12/2007 | WO2007039467A1 Pyrimidine compounds for the treatment of inflammatory disorders |
| 04/12/2007 | WO2007039464A1 Isotopically substituted imidazopyridine derivatives for the treatment of gastrointestinal disorders |
| 04/12/2007 | WO2007039463A1 Nnrt inhibitors |
| 04/12/2007 | WO2007039439A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 04/12/2007 | WO2007039438A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 04/12/2007 | WO2007039420A1 Novel dosage formulation |
| 04/12/2007 | WO2007039417A1 Pharmaceutical preparation containing meloxicam |
| 04/12/2007 | WO2007039404A1 Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
| 04/12/2007 | WO2007039403A1 Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors |
| 04/12/2007 | WO2007039389A1 Isoxazolo derivatives as gaba a alpha5 inverse agonists |
| 04/12/2007 | WO2007039322A1 Use of vitamin d3 compounds for the treatment of uveitis |
| 04/12/2007 | WO2007039297A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 04/12/2007 | WO2007039294A2 Gelling compositions and methods |
| 04/12/2007 | WO2007039286A1 Tetrahydro-pyrrolizinone compounds as lfa-i mediators |
| 04/12/2007 | WO2007039285A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | WO2007039264A1 Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 04/12/2007 | WO2007039226A1 Diazine azole derivatives, their manufacture and use as pharmaceutical agents |
| 04/12/2007 | WO2007039220A1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 04/12/2007 | WO2007039219A1 Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| 04/12/2007 | WO2007039218A1 Hiv integrase inhibitors |
| 04/12/2007 | WO2007039216A1 Phenyl-(4-phenyl-pyrimidin-2-yl)-amines for enhancing immunotolerance |
| 04/12/2007 | WO2007039201A2 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 04/12/2007 | WO2007039176A1 Derivatives of 2 -aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039175A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039173A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039172A1 Phenyl- and pyridyl-i, 2 , 4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039171A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039170A1 Antagonists of topoisomerase activity and their use in inhibiting pathological conditions |
| 04/12/2007 | WO2007039155A2 Use of soluble guanylate cyclase activators for treating acute and chronic lung diseases |
| 04/12/2007 | WO2007039151A1 Blockers of transforming growth factor beta and its receptors for the treatment of infectious diseases |
| 04/12/2007 | WO2007039149A1 Method and composition comprising squalane and / or squalane for treating burn |
| 04/12/2007 | WO2007039146A1 4-carboxy pyrazole derivatives as anti-viral agents |
| 04/12/2007 | WO2007039145A1 C (2) -heteroarylmethyl-c (4) -pyrazinyl-2-yl acyl pyrrolidine compounds and their use for treating viral infections, especially hepatitis c virus |
| 04/12/2007 | WO2007039144A1 Pyrrolidine derivatives for treating viral infections |
| 04/12/2007 | WO2007039143A1 C (2) -heteroarylmethyl-c (4) -pyrazin-2-yl acyl pyrrolidine compounds and their user for treating viral infections, especially hepatitics c (hcv) |
| 04/12/2007 | WO2007039142A1 C (2) -heteroarylmethyl-c (4) -methoxymethyl acyl pyrrolidine compounds and their use for treating viral infections, especially hepatitis c virus |
| 04/12/2007 | WO2007039138A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/12/2007 | WO2007039134A1 Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders |
| 04/12/2007 | WO2007039132A1 Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 04/12/2007 | WO2007039129A1 Combination |
| 04/12/2007 | WO2007039122A2 Solid orally administerable pharmaceutical dosage forms with rapid active principle release |
| 04/12/2007 | WO2007039114A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 04/12/2007 | WO2007039113A1 Novel aromatic compounds and their use in medical applications |
| 04/12/2007 | WO2007039112A1 Novel phloroglucinol derivatives having selectin ligand activity |
| 04/12/2007 | WO2007039111A2 Novel multi-cyclic compounds and their use |